The study found that keeping tight control over blood and brain pressure might improve children’s chances of recovery from a ...

The HALO™ Clarity is powered by Nexalin’s proprietary Deep Intracranial Frequency Stimulation (DIFS) technology, delivering non-invasive, deep-brain stimulation without the use of drugs or invasive ...

Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the other is low, it results in ganglion cell proptosis, leading to glaucoma. KOLOA ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

Patients in the endovascular therapy group achieved greater functional outcomes at 90 days. 2. Endovascular therapy resulted in significantly decreased disability and overall mortality. Evidence ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.